Antibody-independent B cell effector functions in relapsing remitting multiple sclerosis: clues to increased inflammatory and reduced regulatory B cell capacity.
about
B Cells Are Multifunctional Players in Multiple Sclerosis Pathogenesis: Insights from Therapeutic InterventionsMultiple sclerosis: molecular mechanisms and therapeutic opportunitiesInebilizumab, a B Cell-Depleting Anti-CD19 Antibody for the Treatment of Autoimmune Neurological Diseases: Insights from Preclinical StudiesThe antibody genetics of multiple sclerosis: comparing next-generation sequencing to sanger sequencingTreating multiple sclerosis with monoclonal antibodies: a 2013 update.The effect of glatiramer acetate therapy on functional properties of B cells from patients with relapsing-remitting multiple sclerosis.Seeking balance: Potentiation and inhibition of multiple sclerosis autoimmune responses by IL-6 and IL-10.Interleukin-6 gene promoter-572 C allele may play a role in rate of disease progression in multiple sclerosisA Distinct Class of Antibodies May Be an Indicator of Gray Matter Autoimmunity in Early and Established Relapsing Remitting Multiple Sclerosis Patients.Regulatory T Cell Dysfunction Acquiesces to BTLA+ Regulatory B Cells Subsequent to Oral Intervention in Experimental Autoimmune EncephalomyelitisActivation of human B cells negatively regulates TGF-β1 production.CD40-Mediated NF-κB Activation in B Cells Is Increased in Multiple Sclerosis and Modulated by Therapeutics.B cells and antibodies in multiple sclerosis pathogenesis and therapy.Autoimmunity in 2012.A changing treatment landscape for multiple sclerosis: challenges and opportunities.B cells in MS and NMO: pathogenesis and therapy.B Cell-Directed Therapeutics in Multiple Sclerosis: Rationale and Clinical Evidence.Mechanisms by Which B Cells and Regulatory T Cells Influence Development of Murine Organ-Specific Autoimmune DiseasesB-cell targeting agents in the treatment of multiple sclerosis.Fingolimod treatment promotes regulatory phenotype and function of B cells.Deciphering the Role of B Cells in Multiple Sclerosis-Towards Specific Targeting of Pathogenic Function.The CD40-CD40L Dyad in Experimental Autoimmune Encephalomyelitis and Multiple Sclerosis.Polyclonal B cell activation for accurate analysis of pre-existing antigen-specific memory B cells.Cigarette smoke-induced iBALT mediates macrophage activation in a B cell-dependent manner in COPD.Potential Role for Regulatory B Cells as a Major Source of Interleukin-10 in Spleen from Plasmodium chabaudi-Infected Mice.Therapeutic effects of pegylated-interferon-α2a in a mouse model of multiple sclerosis.Dimethyl fumarate induces a persistent change in the composition of the innate and adaptive immune system in multiple sclerosis patients.Impact of Glatiramer Acetate on B Cell-Mediated Pathogenesis of Multiple Sclerosis
P2860
Q26770664-AFED999A-268D-4516-A435-7BE9598600CFQ27023735-2B49EC0C-BABC-4B7D-B2E7-038FE42C916EQ28067334-CAF26966-ED0F-4588-86C0-AA92B24D72CBQ34193087-ED958966-0717-4912-B452-7DF4588DD3E0Q34330211-10A33FFD-6BE3-4722-9992-EDEA376E1226Q35105313-EBE8EAF0-B55A-415D-A906-652AD979CF64Q35625089-6FE3486E-3C73-46B9-A91F-08EBD92CAA33Q36396628-97EFDE7C-F0AB-4A05-8459-E9EBFFABAE1BQ36455070-285FAF77-5DBE-426B-9F95-FBAA025C7D32Q36971195-36F3FDD5-7C3E-44C7-B84B-A3F620CC74D7Q37593519-D6B41F14-2DF9-4D52-9A69-EAE5ADCD52C4Q37645910-B522D76C-7443-4102-866D-2D679AA9832BQ38050398-41C7C3E6-2C38-4E2F-A7AB-B4A01AD77A2EQ38131447-4D14168C-39FB-428A-826A-0CBB35D9EB1DQ38180166-860745D0-4147-4417-901F-D0026090826AQ38212081-A86860FA-7CC7-4F1C-B5CD-E37E4EC9395FQ38795434-7AC519ED-6A67-4BE8-BC57-503F5264D2F4Q39109245-F69B80F0-A3FB-4723-AFDE-4E0641072586Q39431517-EC115AA1-99CD-4BDB-AB06-B7D64CF6436BQ41268957-CA808F37-970A-41B8-B078-EC5A7C0C0E76Q47102132-C297A60B-552E-497B-93CB-C21229CD0DA1Q47221242-72816C22-2E41-45FF-85C4-EFC9B56D10D3Q50858041-412CCEB4-4AA6-405B-B270-DA580B979FDAQ51703615-227A6EF1-5488-4125-9C69-A66625BA4579Q54257360-2FD19126-EA70-4458-AC21-0F7C616008EAQ55054591-DD508FAC-39BB-4197-B7A6-4DA1F144C086Q55117400-516E7C7E-A929-4CEE-B917-43DEE2C47E56Q57470698-E115D072-D270-4EED-98D6-971A7B9F6CD3
P2860
Antibody-independent B cell effector functions in relapsing remitting multiple sclerosis: clues to increased inflammatory and reduced regulatory B cell capacity.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Antibody-independent B cell ef ...... ed regulatory B cell capacity.
@en
Antibody-independent B cell ef ...... ed regulatory B cell capacity.
@nl
type
label
Antibody-independent B cell ef ...... ed regulatory B cell capacity.
@en
Antibody-independent B cell ef ...... ed regulatory B cell capacity.
@nl
prefLabel
Antibody-independent B cell ef ...... ed regulatory B cell capacity.
@en
Antibody-independent B cell ef ...... ed regulatory B cell capacity.
@nl
P2093
P2860
P921
P1433
P1476
Antibody-independent B cell ef ...... ced regulatory B cell capacity
@en
P2093
Christopher T Harp
Elliot M Frohman
Laurie S Davis
Monica Blazek
Nancy L Monson
P2860
P304
P356
10.3109/08916934.2012.665529
P577
2012-04-18T00:00:00Z